UNITED KINGDOM: Dispersal of HIV Positive Asylum Seekers: National Survey of UK Healthcare Providers

Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.

UNITED KINGDOM: Dispersal of HIV Positive Asylum Seekers: National Survey of UK Healthcare Providers

British Medical Journal (08.07.04) Vol. 29; No. 7461: P. 322- 323 - Monday, August 16, 2004
S. Creighton; G. Sethi; S.G. Edwards; R. Miller

Beginning April 2000, the UK National Asylum Support Service initiated a policy of dispersing asylum seekers from London and southeast England to locations around the United Kingdom in an effort to diffuse health care costs. More than 100,000 asylum seekers to date have been dispersed, many of whom are from regions with HIV epidemics. It is not known how many HIV- positive seekers have been affected by the policy. Asylum seekers may receive only 48 hours notice, and they face immediate cessation of income, housing and legal benefits if they decline dispersal.

In the current study, the authors surveyed lead clinicians working in genitourinary medicine clinics about their experiences and opinions of the dispersal of HIV-positive asylum seekers. Centers that do not treat HIV-positive patients were excluded. In December 2003, anonymous questionnaires were out to doctors asking about the appropriateness of dispersal in 10 clinical scenarios and about perceived barriers to effective dispersal.

Fifty-six of 75 eligible centers returned questionnaires; 34 of these were outside London, and 20 had had an HIV-positive asylum seeker dispersed to them. A total of 13 centers reported patients dispersed both to and from them.

Of the 56 returned questionnaires, frequently cited barriers to successful dispersal were dispersal at short notice (37) or with no prior arrangement (43). Just three centers had experienced appropriate transfer of care. Additional barriers cited included lack of community support (41), low staffing levels in the receiving center (40), and lack of facilities to support vulnerable asylum seekers with psychological problems (43).

Some doctors spontaneously listed negative consequences attributed to dispersal, although the questionnaire did not inquire about such. Problems relating to unintentional interruption of antiretroviral therapy (4), mother-to-child HIV transmission (3), and HIV-related death (2) were reported. Many of the 56 returned questionnaires said dispersal of HIV- infected asylum seekers was inappropriate in certain situations - during initiation of HIV therapy (47), in patients receiving salvage treatment (43), in those currently undergoing medical investigations (50), where care involved multiple medical specialties (52), and when patients had progressed to AIDS (45).

Of the potential barriers to safe dispersal of HIV-infected asylum seekers, it is of particular concern that dispersal is done at short notice and frequently without appropriate transfer of medical information, the researchers noted. "Inappropriate dispersal of an HIV infected patient could lead to HIV resistance, onward transmission of HIV infection and avoidable morbidity and mortality for the asylum seeker," the researchers noted. "Before the decision to disperse, the National Asylum Support Service should seek specialist advice and consider the impact on the infrastructure and staffing of the receiving centre," they concluded.
040816
AD041664

Copyright © 2004 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.